Mice Expressing Mutant Myosin Heavy Chains Are a Model for Familial Hypertrophic Cardiomyopathy

作者: Karen L. Vikstrom , Stephen M. Factor , Leslie A. Leinwand

DOI: 10.1007/BF03401640

关键词:

摘要: Familial hypertrophic cardiomyopathy (HCM) is an autosomal dominant disease characterized by ventricular hypertrophy, myocellular disarray, arrhythmias, and sudden death. Mutations in several contractile proteins, including cardiac myosin heavy chains, have been described families with this disease, leading to the hypothesis that HCM a of sarcomere. A mutation chain (Myh) predicted interfere strongly myosin’s binding actin was designed used create animal model for HCM. Five independent lines transgenic mice were produced cardiac-specific expression mutant Myh. Although Myh represents small proportion (1–12%) heart’s myosin, exhibit histopathology seen patients. Histopathology absent from atria primarily restricted left ventricle. The line exhibiting highest level demonstrates hypertrophy 12 weeks age, but further course affected sex animal. Hypertrophy increases age female animals while hearts male show severe dilation 8 months absence increased mass. low levels transgene protein presence phenotypic features suggest acts as negative. In addition, distinct phenotypes developed aging or extragenic factors influence development phenotype.

参考文章(43)
Barry J. Maron, Robert O. Bonow, Richard O. Cannon, Martin B. Leon, Stephen E. Epstein, Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). The New England Journal of Medicine. ,vol. 316, pp. 780- 789 ,(1987) , 10.1056/NEJM198703263161305
Brigid Hogan, Elizabeth Lacy, Frank Costantini, Manipulating the mouse embryo: A laboratory manual ,(1986)
A. Subramaniam, W.K. Jones, J. Gulick, S. Wert, J. Neumann, J. Robbins, Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. Journal of Biological Chemistry. ,vol. 266, pp. 24613- 24620 ,(1991) , 10.1016/S0021-9258(18)54273-3
H.L. Sweeney, A.J. Straceski, L.A. Leinwand, B.A. Tikunov, L. Faust, Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. Journal of Biological Chemistry. ,vol. 269, pp. 1603- 1605 ,(1994) , 10.1016/S0021-9258(17)42067-9
W A Ng, I L Grupp, A Subramaniam, J Robbins, Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. Circulation Research. ,vol. 68, pp. 1742- 1750 ,(1991) , 10.1161/01.RES.68.6.1742
Brigid K. Quinn-Laquer, Jane E. Kennedy, S.Jack Wei, Kirk W. Beisel, Characterization of the allelic differences in the mouse cardiac α-myosin heavy chain coding sequence Genomics. ,vol. 13, pp. 176- 188 ,(1992) , 10.1016/0888-7543(92)90218-H
F.J. ten Cate, J. Roelandt, Progression to left ventricular dilatation in patients with hypertrophic obstructive cardiomyopathy American Heart Journal. ,vol. 97, pp. 762- 765 ,(1979) , 10.1016/0002-8703(79)90012-7
Barry J. Maron, James K. Wolfson, Stephen E. Epstein, William C. Roberts, Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. Journal of the American College of Cardiology. ,vol. 8, pp. 545- 557 ,(1986) , 10.1016/S0735-1097(86)80181-4
A. A. T. Geisterfer-Lowrance, M. Christe, D. A. Conner, J. S. Ingwall, F. J. Schoen, C. E. Seidman, J. G. Seidman, A Mouse Model of Familial Hypertrophic Cardiomyopathy Science. ,vol. 272, pp. 731- 734 ,(1996) , 10.1126/SCIENCE.272.5262.731